Clinical and biologic activity of an estrogenic herbal combination (PC- SPES) in prostate cancer

New England Journal of Medicine

Volumn 339, Issue 12, 1998, Pages 785-791

  Dipaola, Robert S ^a,b   Zhang, Huayan ^a,c   Lambert, George H ^a,b,c   Meeker, Robert ^b,c   Licitra, Edward ^a,b   Rafi, Mohamed M ^a,b   Zhu, Bao Ting ^a,b,c   Spaulding, Heidi ^a,b   Goodin, Susan ^a,b   Toledano, Michel B ^c   Hait, William N ^a,b   Gallo, Michael A ^a,b,c  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DIETHYLSTILBESTROL; DRUG VEHICLE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; GANODERMA LUCIDUM EXTRACT; HERBACEOUS AGENT; PROSTATE SPECIFIC ANTIGEN; SCUTELLARIAE RADIX; SPES; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRYSANTHEMUM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CAPSULE; DRUG EFFECT; DRUG MIXTURE; DRUG POTENCY; ESTROGEN ACTIVITY; FEMALE; GAS CHROMATOGRAPHY; GINSENG; GLYCYRRHIZA; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SENSITIVITY; HUMAN; LIBIDO; MALE; MASS SPECTROMETRY; MASTALGIA; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; SABAL; TESTOSTERONE BLOOD LEVEL; VEIN THROMBOSIS; YEAST;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; LIBIDO; MALE; MICE; PLANT EXTRACTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ESTROGEN; SACCHAROMYCES CEREVISIAE; TESTOSTERONE; THROMBOPHLEBITIS; UTERUS; YEASTS;

EID: 0032541587     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199809173391201     Document Type: Article

References (24)

1. See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 1997;35:229-35.
2. Carraro JC, Raynaud JP, Koch G, et al. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate 1996;29: 231-40.
3. Volz HP. Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatry 1997;30:Suppl 2:72-6.
4. Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T. Cancer patients use of nonproven therapy: a 5 year follow-up study. J Clin Oncol 1998;16:6-12.
5. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-52.
6. Fan S, Wang X. SPES, composition of herbal extracts: U.S. patent number 5,417,979. May 1995.
7. Halicka HD, Ardelt B, Juan G, et al. Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC SPES. Int J Oncol 1997;11:437-8.
8. Hsieh T, Chen SS, Wang X, Wu JM. Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgenresponsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES. Biochem Mol Biol Int 1997;42:535-44.
9. Delos S, Carsol JL, Ghazarossian E, Raynaud JP, Martin PM. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts. J Steroid Biochem Mol Biol 1995;55:375-83.
10. Cott JM. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract. Pharmacopsychiatry 1997;30:Suppl 2:108-12.
11. Zava DT, Bien M, Duwe G. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ Health Perspect 1997;105:Suppl 3:637-45.
12. Duda RB, Taback B, Kessel B, et al. pS2 expression induced by American ginseng in MCF-7 breast cancer cells. Ann Surg Oncol 1996;3:515-20.
13. Pierrat B, Heery DM, Lemoine Y, Losson R. Functional analysis of the human estrogen receptor using a phenotypic trarisactivation assay in yeast. Gene 1992;119:237-45.
14. Suchar LA, Chang RL, Rosen RT, Lech J, Conney AH. High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats. J Pharmacol Exp Ther 1995;272:197-206.
15. Zhu BT, Lech J, Rosen RT, Conney AH. Effect of dietary 2(3)-tert-butyl-4-hydroxyanisole on the metabolism and action of estradiol and estrone in female CD-1 mice. Cancer Res 1997;57:2419-27.
16. The Leuprolide Study Group. Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med 1984;311:1281-6.
17. Droz JP, De Smedt E, Kattan J, et al. Phase I trial of high-dose fostestrol in hormone-refractory adenocarcinoma of the prostate. Prostate 1994;24:62-6.
18. Aprikian AG, Fair WR, Reuter VE, et al. Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer. Br J Urol 1994;74:630-6.
19. Citrin DL, Kies MS, Wallemark CB, et al. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer 1985;56:457-60.
20. McDonnell TJ, Troncoso P, Brisbay SM, et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of an drogen-independcnt prostate cancer. Cancer Res 1992;52:6940-4.
21. Fielden MR, Chen I, Chittim B, Safe SH, Zacharewski TR. Examination of the estrogenicity of 2,4,6,2′6′-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2′6′-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2′4′6′-hexachlorobiphenyl (PCB 155). Environ Health Perspect 1997;105:1238-48.
22. Walker BE. Uterine tumors in old female mice exposed prenatally to diethylstilbestrol. J Natl Cancer Inst 1983;70:477-84.
23. Idem. Complications of pregnancy in mice exposed prenatally to DES. Teratology 1983;27:73-80.
24. Robertson CN, Roberson KM, Padilla GM, et al. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst 1996;88:908-17.